The success of Sildenafil initially sparked a surge for the drug industry, but recent changes present a uncertain scenario for shareholders. Off-patent versions are eroding earnings, and persistent legal battles add https://leawhus778787.csublogs.com/49049277/sildenafil-and-pharma-a-precarious-play